ethylmaleimide has been researched along with Leukemia, T-Cell in 2 studies
Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies.
Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ståhls, A | 1 |
| Fisher, RJ | 1 |
| Koizumi, S | 1 |
| Kondoh, A | 1 |
| Mariano, JM | 1 |
| Mavrothalassitis, G | 1 |
| Bhat, NK | 1 |
| Papas, TS | 1 |
2 other studies available for ethylmaleimide and Leukemia, T-Cell
| Article | Year |
|---|---|
The sulfhydryl reagent N-ethylmaleimide induces hyperphosphorylation on tyrosine residues in the Jurkat T-cell line.
Topics: Antigens, CD; Dithiothreitol; Ethylmaleimide; Histocompatibility Antigens; Humans; Immunosorbent Tec | 1992 |
Human ETS1 oncoprotein. Purification, isoforms, -SH modification, and DNA sequence-specific binding.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Base Sequence; Cell Line; Cell Nucleus; Centrifugation, | 1992 |